CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The Mpox AFRIVAC Project aims to adapt a clinical trial for pre-exposure vaccination against Mpox to African contexts. It focuses on developing diagnostics and enhancing local capacity to respond effectively to the ongoing Mpox outbreak in the Democratic Republic of Congo.
The current Mpox outbreak affecting the Democratic Republic of the Congo, ongoing since 2023, has resulted in more than 19,000 causes and over 1,000 deaths, with women accounting for more than half of those affected.
The previous global Mpox outbreak in 2022 was alleviated in part with use of preventive vaccination using modified vaccina Ankara (MVA) vaccine.
However, whether this vaccine induces sufficient immune responses in women and those with immunosuppression, which is common in affected a…
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
MAKERERE UNIVERSITY LUNG INSTITUTE
Uganda, KAMPALA
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
United Kingdom, St Andrews
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Congo - Kinshasa, BUKAVU
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
